Company Filing History:
Years Active: 1997-2011
Title: Innovations of Timothy A Mietzner in Antimicrobial Peptides
Introduction
Timothy A Mietzner is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of antimicrobial peptides, holding a total of 6 patents. His work focuses on developing innovative solutions for treating and preventing infectious diseases.
Latest Patents
Mietzner's latest patents include the invention of virus-derived antimicrobial peptides. These peptides exhibit antimicrobial activity and are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The antimicrobial peptides, designated LBU, WLBU, and WR, are derived from LLP1 analogs and demonstrate effectiveness in various contexts, including the treatment of infectious diseases. The methods described in his patents include killing fungi and bacteria, as well as neutralizing enveloped viruses such as poxvirus, herpesvirus, and HIV-1. The peptides can be presented in soluble form or attached to solid surfaces, making them versatile in application.
Career Highlights
Timothy A Mietzner is affiliated with the University of Pittsburgh, where he continues to advance research in antimicrobial peptides. His innovative work has garnered attention in the scientific community, contributing to the understanding and development of effective antimicrobial agents.
Collaborations
Mietzner has collaborated with notable colleagues, including Ronald C Montelaro and Sarah Burroughs Tencza. These collaborations have further enriched his research and development efforts in the field of antimicrobial peptides.
Conclusion
Timothy A Mietzner's contributions to the field of antimicrobial peptides represent a significant advancement in the fight against infectious diseases. His innovative patents and collaborative efforts continue to pave the way for new therapeutic solutions.